Many Legal Marijuana Products Too Strong for Treating Pain
Majority of products in medicinal, recreational programs advertised to have >15 percent THC
Weight Loss Modest for Most Macronutrient Diets
Weight loss, CV risk factors improved over six months, but benefits mainly diminished at 12 months
ENDO: Real-World Data Analyzed for Use of Insulin Pump in T1DM
Subgroup analysis shows time spent in target glucose range increased in auto mode versus manual mode
Unemployed Workers Less Likely to Be Uninsured Post-ACA
Following implementation of ACA, insurance rates decreased more in states with Medicaid expansion
ENDO: Glycemic Control Good for Regular Human Insulin With V-Go
Mean change in HbA1c not significantly different with regular human insulin, rapid-acting insulin
ENDO: Liraglutide May Benefit Adolescents With Obesity
Reduction in BMI standard-deviation score greater for liraglutide + lifestyle therapy versus placebo
March 2020 Briefing – Diabetes & Endocrinology
Here are what the editors at HealthDay consider to be the most important developments in Diabetes & Endocrinology for March 2020. This roundup includes...
ENDO: Real-World Data Analyzed for Use of Insulin Pump in T1DM
Subgroup analysis shows time spent in target glucose range increased in auto mode versus manual mode
Severe COVID-19 Risk Up With Existing Health Conditions in U.S.
Most commonly reported underlying health conditions were diabetes, chronic lung disease, CVD
ENDO: Diabetes Diminishes Weight Loss Effect of Bariatric Surgery
Those without diabetes had increased odds of achieving 50 percent or more excess body-weight loss
